Skip to main content

Candriam S.C.A.

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1537014 STRASSEN, N4

Position in BBIO

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$20,710,222
-$621,921 QoQ
Shares Held
278,888
0.0% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Candriam S.C.A. holds $1,920,933,361 across 79 Biotechnology names. BBIO ranks #34 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BBIO

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,710,222 278,888
2025-12-31 $21,332,143 278,888
2025-09-30 $7,738,332 148,986
2024-03-31 $11,749,600 380,000
2023-12-31 $12,070,630 299,000
2023-09-30 $6,460,650 245,000
2023-06-30 $4,902,000 285,000
2023-03-31 $4,725,300 285,000
2022-12-31 $733,379 96,244
2022-09-30 $952,003 95,775
2022-06-30 $3,649,360 401,912
2022-03-31 $4,079,406 401,912
2021-12-31 $6,703,892 401,912
2021-09-30 $21,339,207 455,285
2021-06-30 $27,754,173 455,285